Montrusco Bolton Investments Inc. Biogen Inc. Transaction History

Montrusco Bolton Investments Inc.

$8.05 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $12.9 Million - $19.4 Million	-54,622 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $699,257 - $807,380	2,641 Added 5.08%	54,622 $15 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $21.2 Million - $28.1 Million	-82,143 Reduced 61.24%	51,981 $13.8 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $23.6 Million - $29.9 Million	87,756 Added 189.26%	134,124 $40.7 Million
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $9.42 Million - $13 Million	-42,804 Reduced 48.0%	46,368 $13.3 Million
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $228,746 - $256,561	1,052 Added 1.19%	89,172 $26.1 Million
Q2 2019 Aug 05, 2019	BUY	$219.29 - $241.72 $5.4 Million - $5.96 Million	24,636 Added 38.81%	88,120 $20.2 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $623,474 - $975,187	2,877 Added 4.75%	63,484 $14.3 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $1.19 Million - $1.5 Million	4,266 Added 7.57%	60,607 $18 Million
Q3 2018 Oct 10, 2018	BUY	$293.51 - $383.83 $3.96 Million - $5.18 Million	13,490 Added 31.48%	56,341 $19.9 Million
Q2 2018 Jul 11, 2018	SELL	$257.52 - $306.91 $1.26 Million - $1.51 Million	-4,907 Reduced 10.27%	42,851 $12.4 Million
Q1 2018 Apr 05, 2018	BUY	$260.13 - $367.91 $2.79 Million - $3.94 Million	10,713 Added 28.92%	47,758 $13 Million
Q4 2017 Jan 12, 2018	SELL	$307.64 - $344.58 $739,258 - $828,025	-2,403 Reduced 6.09%	37,045 $11.8 Million
Q3 2017 Oct 18, 2017	BUY	$281.15 - $329.69 $209,456 - $245,619	745 Added 1.92%	39,448 $12.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	38,703	38,703 $10.5 Million

Others Institutions Holding BIIB

# of Institutions

990

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montrusco Bolton Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Montrusco Bolton Investments Inc. with notifications on news.

Account